SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002700
Filing Date
2019-04-29
Accepted
2019-04-29 17:22:24
Documents
8
Period of Report
2019-06-27
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238631zdef14a.htm DEF 14A 1030087
2 G366326.JPG g366326.jpg GRAPHIC 23459
3 G650180.JPG g650180.jpg GRAPHIC 8714
4 G245976.JPG g245976.jpg GRAPHIC 8525
5 G238227.JPG g238227.jpg GRAPHIC 31971
6 G639415.JPG g639415.jpg GRAPHIC 32116
7 G24782BEI001.GIF g24782bei001.gif GRAPHIC 84287
8 G24782BEI002.GIF g24782bei002.gif GRAPHIC 57256
  Complete submission text file 0001047469-19-002700.txt   1371342
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33497 | Film No.: 19777162
SIC: 2834 Pharmaceutical Preparations